Geoffrey Cumming

Mr Cumming has held roles in the global healthcare and biotechnology sector for more than 20 years. As Managing Director, Roche Diagnostic Systems (Oceania), Dr Cumming transformed the loss-making entity the Swiss parent was intending to divest, into the growing and profitable affiliate in the Roche group. In his role as Managing Director/CEO of Biosceptre International Ltd, Dr Cumming was in designing and securing funding arrangements through a range of capital raising initiatives, including government grants, partnering and co-development deals. He was previously Chairman of Sienna Cancer Diagnostics Ltd. Dr Cumming is a member of the Risk Committee.